OBJECTIVE: To investigate the incidence, clinical features, and treatment of perinatal cytomegalovirus (CMV) infection, as well as the factors affecting the therapeutic effect of ganciclovir. METHODS: The clinical data of 237 infants who were hospitalized and diagnosed with perinatal CMV infection from 2008 to 2012 were retrospectively analyzed. RESULTS: The clinical features of infants with perinatal CMV infection and the proportion of such infants in all hospitalized infants showed no significant differences across the five years. In most infants, two or more systems were involved, and CMV hepatitis plus CMV pneumonia was most common (43.1%). The results of pathogen detection showed that the percentage of the infants with positive blood CMV-IgM and blood/urine CMV-DNA was 3.8%, while 90.3% of all infants had positive blood CMV-IgM alone and 5.9% had positive blood/urine CMV-DNA alone. A total of 197 infants were treated with ganciclovir, and the cure rate was 88.3%. An abnormal history of pregnancy (OR=6.191, 95% CI: 1.597-24.002) and liver involvement before medication (OR=3.705, 95% CI: 1.537-8.931) were the independent risk factors affecting the therapeutic effect of ganciclovir in infants with perinatal CMV infection. CONCLUSIONS: The epidemiological characteristics of perinatal CMV infection have remained generally stable for the last 5 years. CMV often involves several organs or systems, especially the liver and lung. Ganciclovir has a significant efficacy in the treatment of perinatal CMV infection, and an abnormal history of pregnancy and liver involvement before medication can increase the risk of ganciclovir resistance in infants with perinatal CMV infection.
OBJECTIVE: To investigate the incidence, clinical features, and treatment of perinatal cytomegalovirus (CMV) infection, as well as the factors affecting the therapeutic effect of ganciclovir. METHODS: The clinical data of 237 infants who were hospitalized and diagnosed with perinatal CMV infection from 2008 to 2012 were retrospectively analyzed. RESULTS: The clinical features of infants with perinatal CMV infection and the proportion of such infants in all hospitalized infants showed no significant differences across the five years. In most infants, two or more systems were involved, and CMV hepatitis plus CMV pneumonia was most common (43.1%). The results of pathogen detection showed that the percentage of the infants with positive blood CMV-IgM and blood/urine CMV-DNA was 3.8%, while 90.3% of all infants had positive blood CMV-IgM alone and 5.9% had positive blood/urine CMV-DNA alone. A total of 197 infants were treated with ganciclovir, and the cure rate was 88.3%. An abnormal history of pregnancy (OR=6.191, 95% CI: 1.597-24.002) and liver involvement before medication (OR=3.705, 95% CI: 1.537-8.931) were the independent risk factors affecting the therapeutic effect of ganciclovir in infants with perinatal CMV infection. CONCLUSIONS: The epidemiological characteristics of perinatal CMV infection have remained generally stable for the last 5 years. CMV often involves several organs or systems, especially the liver and lung. Ganciclovir has a significant efficacy in the treatment of perinatal CMV infection, and an abnormal history of pregnancy and liver involvement before medication can increase the risk of ganciclovir resistance in infants with perinatal CMV infection.
Authors: Lena Fischer; Kerstin Laib Sampaio; Gerhard Jahn; Klaus Hamprecht; Katharina Göhring Journal: Antiviral Res Date: 2013-10-10 Impact factor: 5.970
Authors: Lenore Pereira; Matthew Petitt; Alex Fong; Mitsuru Tsuge; Takako Tabata; June Fang-Hoover; Ekaterina Maidji; Martin Zydek; Yan Zhou; Naoki Inoue; Sanam Loghavi; Samuel Pepkowitz; Lawrence M Kauvar; Dotun Ogunyemi Journal: J Infect Dis Date: 2014-01-07 Impact factor: 5.226
Authors: Zin Naing; Benjamin Rayner; Ananthen Killikulangara; Krishna Vunnam; Steven Leach; Christopher J McIver; Gillian M Scott; Maria E Craig; Kei Lui; William D Rawlinson Journal: J Paediatr Child Health Date: 2013-02-22 Impact factor: 1.954
Authors: Ivan S Ivanov; Nikolay I Popov; Rumyana I Moshe; Dora D Terzieva; Rumen S Stefanov; Margarita V Panova; Maria V Atanasova; Ben Zion Garty Journal: Folia Med (Plovdiv) Date: 2012 Oct-Dec
Authors: Ricardo V Narvaez-Arzate; Leticia Olguin-Mexquitic; Victoria Lima-Rogel; Daniel E Noyola; Lidia M Barrios-Compean; Carolina Villegas-Alvarez Journal: J Matern Fetal Neonatal Med Date: 2013-02-27